Lexaria Bioscience Corp. — Director's Dealing 2019

Feb 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: Spissinger Allan Horst (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-15	common shares	M	50000	$0.37	Acquired	119116	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-15	Stock Options	$0.37	M	50000	Disposed	2022-06-01	Common Shares (50000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	69166	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.37	2022-06-01	Common Shares (200000)	200000	Direct
Stock Options	$0.83	2022-12-01	Common Shares (200000)	400000	Direct
Stock Options	$1.53	2023-05-31	Common Shares (300000)	700000	Direct